Gibson Dunn & Crutcher advised Veritas Capital and Frontgrade Technologies on the transaction. Frontgrade Technologies, a leading provider of high-reliability electronic solutions for space and national...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher advised Crestview Partners on the transaction, while Blake, Cassels & Graydon and Fox Rothschild advised Novacap. Crestview Partners (“Crestview”) announced its acquisition...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher advised OneMagnify on the transaction. OneMagnify, a global leader in advanced analytics, customer insights, and AI-powered marketing solutions, backed by private equity...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher advised J.P. Morgan on the transaction. Olipop, a prebiotic beverage company, raised $50 million in a Series C funding round that valued...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher advised Cotiviti on the transaction, Covington & Burling advised Cotiviti, and Kirkland & Ellis advised Francisco Partners and TA Associates on the...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher advised OceanSound Partners and its portfolio company DMI on the deal. DMI, a leading provider of digital services and technology solutions, announced...
You must be a Standard 1 Year member to access this content.
Gibson Dunn advised IPI Partners on the deal, and Kirkland & Ellis advised Blue Owl Capital. Blue Owl Capital Inc. (“Blue Owl”) (NYSE: OWL), a leading...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher represented Veritas Capital in the transaction, and King & Spalding represented NCR Voyix Corporation. NCR Voyix Corporation (NYSE: VYX) (“NCR Voyix” or...
You must be a Standard 1 Year member to access this content.
Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher is advising Hologic, Inc. on the transaction. Hologic, Inc. (Nasdaq: HOLX) announced the acquisition of Endomagnetics Ltd, a privately held developer of breast cancer surgery technologies,...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised PAR Technology Corporation on the transaction. PAR Technology Corporation (NYSE: PAR) (the “Company” or “PAR”) announced it has completed the acquisition of Stuzo...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised PAR Technology Corporation on the transaction, and Winston & Strawn represented Longshore Capital Partners, as the Seller Representative. PAR Technology Corporation...
You must be a Standard 1 Year member to access this content.
